Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorADVANCED MARKER DISCOVERY S.L.
About this trial
This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.
Eligibility criteria
Qualifiers
Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).
Disqualifiers
Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
Patients who have received previous chemotherapy or radiotherapy.
Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.
Patients with inadequate bowel preparation for colonoscopy.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
510 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov